908 Devices Inc. (MASS)
NASDAQ: MASS · Real-Time Price · USD
5.73
+0.11 (1.96%)
At close: May 12, 2025, 4:00 PM
5.60
-0.13 (-2.27%)
After-hours: May 12, 2025, 7:31 PM EDT
908 Devices Employees
908 Devices had 246 employees as of December 31, 2024. The number of employees increased by 16 or 6.96% compared to the previous year.
Employees
246
Change (1Y)
16
Growth (1Y)
6.96%
Revenue / Employee
$242,402
Profits / Employee
-$293,520
Market Cap
204.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 246 | 16 | 6.96% |
| Dec 31, 2023 | 230 | 3 | 1.32% |
| Dec 31, 2022 | 227 | 50 | 28.25% |
| Dec 31, 2021 | 177 | 76 | 75.25% |
| Dec 31, 2020 | 101 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MASS News
- 12 days ago - 908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection - Business Wire
- 20 days ago - 908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation - Business Wire
- 2 months ago - 908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - Business Wire
- 2 months ago - 908 Devices Makes Key Divestiture (Rating Upgrade) - Seeking Alpha
- 2 months ago - 908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - Benzinga
- 2 months ago - 908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Business Wire
- 2 months ago - 908 Devices to Participate in Upcoming Investor Conferences - Business Wire